Welcome To SciTalk.com
SciTalk.com
Home Page
Allergies
Breast Cancer
Cardiovascular
Diabetes
Osteoporosis
Prostate Cancer
BioCareer.com
Home Page
Search For Jobs
Post Your Resume
Search The Resumes
Post Your Jobs
Resources
SciJobs.com
Home Page
Search For Jobs
Post Your Resume
Search For Resumes
Post Your Jobs
SciWeb.com
Home Page
Company Directory
Press Releases
Product Announcements
Meeting Announcements
Web Sites
News
Protocols
Equipment and Reagents
NewsWise
Discussion Board

The Breast Cancer Patent Center

Patent Issued  Title Score
US05741649 04/21/1998 Method and kit for detecting breast cancer cells 99%
US05759776 06/02/1998 Targets for breast cancer diagnosis and treatment 98%
US05709999 01/20/1998 Linked breast and ovarian cancer susceptibility gene 98%
US05776683 07/07/1998 Methods for identifying genes amplified in cancer cells 97%
US05753441 05/19/1998 170-linked breast and ovarian cancer susceptibility gene 97%
US05710001 01/20/1998 17q-linked breast and ovarian cancer susceptibility gene 97%
US05800814 09/01/1998 Method for inhibition of breast tumor growth 96%
US05770609 06/23/1998 Prevention and treatment of cardiovascular pathologies 96%
US05837492 11/17/1998 Chromosome 13-linked breast cancer susceptibility gene 95%
US05821254 10/13/1998 Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer 95%
US05804396 09/08/1998 Assay for agents active in proliferative disorders 95%
US05789427 08/04/1998 Methods and compositions for inhibiting cell proliferative disorders 95%
US05721345 02/24/1998 Prevention of mammary carcinogenesis and breast cancer treatment 95%
US05872114 02/16/1999 Therapeutic methods and delivery systems utilizing sex steroid precursors 94%
US05843932 12/01/1998 Therapeutic methods and delivery systems utilizing sex steroid precursors 94%
US05837700 11/17/1998 Therapeutic methods and delivery systems utilizing sex steroid precursors 94%
US05824671 10/20/1998 Therapeutic methods and delivery systems utilizing sex steroid precursors 94%
US05807849 09/15/1998 Therapeutic methods and delivery systems utilizing sex steroid precursors 94%
US05798347 08/25/1998 Therapeutic methods and delivery systems utilizing sex steroid precursors 94%
US05780460 07/14/1998 Therapeutic methods and delivery systems utilizing sex steroid precursors 94%
US05776923 07/07/1998 Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone 94%
US05773476 06/30/1998 Methods and compositions for inhibiting cell proliferative disorders 94%
US05728688 03/17/1998 Therapeutic methods and delivery systems utilizing sex steroid precursors 94%
US05854229 12/29/1998 Therapeutic methods and delivery systems utilizing sex steroid precursors 93%
US05847007 12/08/1998 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells 93%
US05843435 12/01/1998 Immunotherapy of cancer with allogeneic lymphocytes 93%
US05770176 06/23/1998 Assays for functional nuclear receptors 93%
US05872217 02/16/1999 Antibodies which specifically bind a cancer related antigen 92%
US05864011 01/26/1999 Cancer related antigen 92%
US05759837 06/02/1998 Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway 92%
US05710173 01/20/1998 Thienyl compounds for inhibition of cell proliferative disorders 92%
US05869618 02/09/1999 Antibodies to ligand growth factors 91%
US05869445 02/09/1999 Methods for eliciting or enhancing reactivity to HER-2/neu protein 91%
US05798266 08/25/1998 Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer 91%
US05773459 06/30/1998 Urea- and thiourea-type compounds 91%
US05766571 06/16/1998 Method of treating human breast cancer by administration of radiolabeled antibody and unsaturated fatty acids 91%
US05760066 06/02/1998 Compounds and methods for inhibiting hyper-proliferative cell growth 91%
US05846538 12/08/1998 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated 90%
US05801005 09/01/1998 Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated 90%
US05788964 08/04/1998 Method for sensitization of cancer cells for killer cell mediated lysis 90%
US05773479 06/30/1998 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells 90%
US05753229 05/19/1998 Monoclonal antibodies reactive with tumor proliferating cells 90%
US05723302 03/03/1998 Detection of prostate-specific antigen in breast tumors 90%
US05721277 02/24/1998 Compounds and methods for inhibiting hyper-proliferative cell growth 90%
US05861387 01/19/1999 Controlled release systems and low dose androgens 89%
US05854009 12/29/1998 Method of detecting estrogen-sensitive pathologies 89%
US05846960 12/08/1998 Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds 89%
US05776738 07/07/1998 Method of human prohibitin gene analysis 89%
US05726023 03/10/1998 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated 89%
US05862304 01/19/1999 Method for predicting the future occurrence of clinically occult or non-existent medical conditions 88%
US05849876 12/15/1998 Hybridomas producing monoclonal antibodies to new mucin epitopes 88%
US05834504 11/10/1998 3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease 88%
US05811447 09/22/1998 Therapeutic inhibitor of vascular smooth muscle cells 88%
US05763470 06/09/1998 Benzopyran compounds and methods for their use 88%
US05750400 05/12/1998 Coding sequences of the human BRCA1 gene 88%
US05733925 03/31/1998 Therapeutic inhibitor of vascular smooth muscle cells 88%
US05855889 01/05/1999 Mammaglobin, a mammary-specific breast cancer protein 87%
US05792783 08/11/1998 3-heteroaryl-2-indolinone compounds for the treatment of disease 87%
US05763164 06/09/1998 Immunogenic cancer proteins and peptides and methods of use 87%
US05728579 03/17/1998 DNA encoding Mat-8 87%
US05871917 02/16/1999 Identification of differentially methylated and mutated nucleic acids 85%
US05856340 01/05/1999 Method of treating estrogen dependent cancers 85%
US05851830 12/22/1998 Luminal epithelial antigen 85%
US05840507 11/24/1998 Methods for cancer prognosis and diagnosis 85%
US05827666 10/27/1998 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof 85%
US05814340 09/29/1998 Controlled release systems and low dose androgens 85%
US05814315 09/29/1998 Methods for the suppression of neu mediated phenotype in tumors 85%
US05808111 09/15/1998 Stable acitretinoid compounds 85%
US05769074 06/23/1998 Computer assisted methods for diagnosing diseases 85%
US05756294 05/26/1998 Susceptibility mutation for breast and ovarian cancer 85%
US05753204 05/19/1998 Biosynthetic binding proteins for immunotargeting 85%
US05874431 02/23/1999 Benzazole compounds 84%
US05874285 02/23/1999 Polynucleotide encoding a novel human nm23-like protein 84%
US05869238 02/09/1999 Quantitative method of measuring metastatic activity 84%
US05866323 02/02/1999 Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor .beta. and homologous growth controlling factors 84%
US05858192 01/12/1999 Method and apparatus for manipulation using spiral electrodes 84%
US05856351 01/05/1999 Artemisinin dimer compounds having anticancer activity 84%
US05846749 12/08/1998 Quantitative measurement of tissue protein identified by immunohistochemistry and standardized protein determination 84%
US05837846 11/17/1998 Biosynthetic binding proteins for immuno-targeting 84%
US05801222 09/01/1998 Isolation and structure of the human cancer cell growth inhibitory cyclic octapeptides phakellistatin 10 and 11 84%
US05792748 08/11/1998 Method for inhibiting neoplastic disease in mammals 84%
US05786362 07/28/1998 Method of treating Hormone independent cancer 84%
US05769779 06/23/1998 Method and apparatus for accurate radiation dosage control in breast cancer treatment 84%
US05760000 06/02/1998 Inhibition of liver cancer by the use of GnRH and GnRH analogs 84%
US05753618 05/19/1998 Somatostatin analogue composition and use in treating breast cancer 84%
US05747469 05/05/1998 Methods and compositions comprising DNA damaging agents and p53 84%
US05744303 04/28/1998 Functional assay for transcriptional regulator genes 84%
US05710162 01/20/1998 Condensed-indan derivatives and pharmaceutically acceptable salts thereof 84%
US05705508 01/06/1998 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment 84%
US05705151 01/06/1998 Gene therapy for T cell regulation 84%
US05874415 02/23/1999 Enhancer sequence for modulating expression in epithelial cells 82%
US05874266 02/23/1999 Targeted system for removing tumor cells from cell populations 82%
US05874222 02/23/1999 M6P/IGF-II receptor tumor suppressor gene 82%
US05866603 02/02/1999 Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use 82%
US05859206 01/12/1999 Antibodies specific for heregulin 2-.alpha. 82%
US05858365 01/12/1999 Methods for the treatment of wounds using butyric acid salts and derivatives 82%
US05840502 11/24/1998 Methods for enriching specific cell-types by density gradient centrifugation 82%
US05837251 11/17/1998 Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases 82%
US05837233 11/17/1998 Method for treating tumors 82%
US05834476 11/10/1998 Hexa-cyclic compound 82%
US05833634 11/10/1998 Tissue examination 82%
US05827892 10/27/1998 Use of droloxifene for the treatment of cardiovascular diseases 82%
US05821337 10/13/1998 Immunoglobulin variants 82%
US05792845 08/11/1998 Nucleotides encoding angiostatin protein and method of use 82%
US05776759 07/07/1998 Two novel human cathepsin proteins 82%
US05776676 07/07/1998 HME1 nucleic acids and probes 82%
US05776095 07/07/1998 Method and kit for imaging and treating organs and tissues 82%
US05776094 07/07/1998 Method and kit for imaging and treating organs and tissues 82%
US05770567 06/23/1998 Sensory and motor neuron derived factor (SMDF) 82%
US05763213 06/09/1998 Sensory and motor neuron derived factor (SMDF) 82%
US05762903 06/09/1998 Radioactive chitosan complex for radiation therapy 82%
US05759783 06/02/1998 Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene 82%
US05753639 05/19/1998 Low dose androgenic compounds for prevention and treatment of endometriosis 82%
US05747261 05/05/1998 Protein related to but distinct from EGF receptor and antibodies reactive therewith 82%
US05731159 03/24/1998 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof 82%
US05723291 03/03/1998 Methods for screening compounds for estrogenic activity 82%
US05712305 01/27/1998 Antineoplastic cocoa extracts and methods for making and using the same 82%
US05874412 02/23/1999 Bis-anthracyclines with high activity against doxorubicin resistant tumors 80%
US05872150 02/16/1999 Treatment of prostate disease with a nonsteroidal anti-androgenic compound 80%
US05869606 02/09/1999 Amino acids peptides or derivatives thereof coupled to fats 80%
US05869485 02/09/1999 Pyrrolo[2,3-d]pyrimidines and their use 80%
US05866558 02/02/1999 6-alkynyl steroids 80%
US05866550 02/02/1999 Method of inhibiting replication of hyperproliferative cells using a nucleic acid encoding EIA 80%
US05863911 01/26/1999 Diarylethylene metallocene derivatives, their processes of preparation and pharmaceutical compositions containing said derivatives 80%
US05861406 01/19/1999 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles 80%
US05861390 01/19/1999 Steroid sulphatase inhibitors 80%
US05861248 01/19/1999 Biomarkers for detection of prostate cancer 80%
US05859013 01/12/1999 Method for inducing death of neoplastic cells using piperazine derivatives 80%
US05857463 01/12/1999 Remotely controlled apparatus and system for tracking and locating a source of photoemissions 80%
US05856665 01/05/1999 Arc lamp stabilization and intensity control for imaging microscopy 80%
US05856110 01/05/1999 Method of using HRG2-.alpha. to stimulate P185HeR2 80%
US05852059 12/22/1998 Use of droloxifene for the treatment of protastic disease, endometriosis and obesity 80%
US05851991 12/22/1998 Therapeutic use of the retinoblastoma susceptibility gene product 80%
US05851792 12/22/1998 Aglucone isoflavone enriched vegetable protein whey whey protein material aglucone isoflavone material high genistein content material and high daidzein content material and process for producing the same from a vegetable protein whey 80%
US05849881 12/15/1998 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms 80%
US05846548 12/08/1998 Combined administration of mitogenic immumo stimulator and a thymomimetic 80%
US05845254 12/01/1998 Method and apparatus for objectively monitoring and assessing the performance of health-care providers based on the severity of sickness episodes treated by the providers 80%
US05843994 12/01/1998 Compositions and methods for treating and preventing pathologies including cancer 80%
US05840687 11/24/1998 Modified ligands for receptor tyrosine kinases 80%
US05840525 11/24/1998 Nucleic acids, vectors and host cells encoding heregulin 80%
US05840514 11/24/1998 Methods of testing cancer and anticancer drugs 80%
US05837830 11/17/1998 Stereodirected process for synthesis of .alpha.-N-acetylgalactosaminides 80%
US05837815 11/17/1998 PYK2 related polypeptide products 80%
US05837677 11/17/1998 Method for the treatment of cancer with Exochelins of Mycobacterium tuberculosis 80%
US05837541 11/17/1998 Cross-protective human monoclonal antibody compositions 80%
US05837524 11/17/1998 PYK2 related polynucleotide products 80%
US05833994 11/10/1998 Use of the AH receptor and AH receptor ligands to treat or prevent cytopathicity of viral infection 80%
US05830886 11/03/1998 Steroid sulphatase inhibitors 80%
US05830660 11/03/1998 Tumorigenesis protein 80%
US05827721 10/27/1998 BH55 hyaluronidase 80%
US05827682 10/27/1998 Two-step conversion of vegetable protein isoflavone conjugates to aglucones 80%
US05824311 10/20/1998 Treatment of tumors with monoclonal antibodies against oncogene antigens 80%
US05817816 10/06/1998 Sesquiterpene derivatives having progesterone receptor binding inhibitory activity 80%
US05814609 09/29/1998 Compositions containing a disintegrin and methods for its use in preventing metastasis and other conditions 80%
US05810742 09/22/1998 Tissue characterization based on impedance images and on impedance measurements 80%
US05808005 09/15/1998 Human carcinoma antigen 80%
US05807989 09/15/1998 Methods for treatment or diagnosis of diseases or disorders associated with an APB domain 80%
US05807257 09/15/1998 Breast cancer detection, imaging and screening by electromagnetic millimeter waves 80%
US05803082 09/08/1998 Omnispectramammography 80%
US05800820 09/01/1998 Methods and compositions for treatment of angiogenic diseases 80%
US05798374 08/25/1998 Methods of inhibiting phosphatase activity and treatment of disorders associated therewith 80%
US05790710 08/04/1998 Autofocus system for scanning microscopy 80%
US05789432 08/04/1998 Aromatase-inhibiting composition containing azole derivative 80%
US05783562 07/21/1998 Luteinizing hormone releasing hormone analogs 80%
US05780592 07/14/1998 Compositions comprising lipoproteins and crotonamide derivatives 80%
US05780496 07/14/1998 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions 80%
US05776913 07/07/1998 Therapeutic diet for metabolic abnormalities found in animals with lymphoma 80%
US05773215 06/30/1998 Tumor marker protein for cancer risk assessment 80%
US05772997 06/30/1998 Monoclonal antibodies directed to the HER2 receptor 80%
US05770593 06/23/1998 Method of determining a pharmaceutical combination preparations for use in anti-neoplastic therapy 80%
US05770195 06/23/1998 Monoclonal antibodies directed to the her2 receptor 80%
US05766939 06/16/1998 Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms 80%
US05766222 06/16/1998 Nipple illuminator for photodynamic therapy 80%
US05763484 06/09/1998 Lipids for treatment of disease 80%
US05763216 06/09/1998 Gene encoding a human reduced folate carrier (RFC) 80%
US05762958 06/09/1998 Multilipid component ether lipid liposomes 80%
US05760086 06/02/1998 Nasal administration of agents for treatment of delayed onset emesis 80%
US05759791 06/02/1998 Cancer related antigen 80%
US05759782 06/02/1998 Cellular apoptosis susceptibility protein (CSP) and antisense CSP 80%
US05756696 05/26/1998 Compositions for chromosome-specific staining 80%
US05756456 05/26/1998 Methods involving sensory and motor neuron derived factor (SMDF) 80%
US05751787 05/12/1998 Materials and methods for improved radiography 80%
US05750576 05/12/1998 Triphenylethylenes for the prevention and treatment of osteoporosis 80%
US05750547 05/12/1998 Certain carbanate anti-cancer agents 80%
US05747510 05/05/1998 Pharmaceutical unit dosage formulations 80%
US05744460 04/28/1998 Combination for treatment of proliferative diseases 80%
US05736517 04/07/1998 Treatment of cancer with peptides 80%
US05733911 03/31/1998 Method for inducing death of neoplastic cells using piperazne derivatives 80%
US05733902 03/31/1998 Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors 80%
US05732704 03/31/1998 Radiation based method locating and differentiating sentinel nodes 80%
US05731328 03/24/1998 Methods of inhibiting plasminogen activator inhibitor 1 80%
US05725856 03/10/1998 Monoclonal antibodies directed to the HER2 receptor 80%
US05720954 02/24/1998 Monoclonal antibodies directed to the HER2 receptor 80%
US05716788 02/10/1998 Antibodies to human reduced folate carrier protein 80%
US05708163 01/13/1998 Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof 80%
US05708156 01/13/1998 Epidermal growth factor receptor-like gene product and its uses 80%
US05707963 01/13/1998 Methods of using growth inhibitory peptides 80%
US05705157 01/06/1998 Methods of treating cancerous cells with anti-receptor antibodies 80%
US05704355 01/06/1998 Non-invasive system for breast cancer detection 80%
US05874534 02/23/1999 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy 77%




Copyright © 1996-2008 SciWeb, Inc.
Please Read Our Disclaimer
Site and Database Design by SciWeb Inc. ™
The Life Science Home Page